Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers Article

Chiquette, Elaine, Toth, Peter P, Ramirez, Gilbert et al. (2012). Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers . Vascular Health and Risk Management, 8 621-629. 10.2147/VHRM.S37969

cited authors

  • Chiquette, Elaine; Toth, Peter P; Ramirez, Gilbert; Cobble, Michael; Chilton, Robert

authors

publication date

  • January 1, 2012

published in

keywords

  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Peripheral Vascular Disease
  • Science & Technology
  • dyslipidemia
  • glucagon-like protein-1 receptor agonist
  • incretin mimetic
  • type 2 diabetes mellitus

Digital Object Identifier (DOI)

start page

  • 621

end page

  • 629

volume

  • 8